Ability of serum alkaline phosphatase (ALP) changes to complement PSA changes and predict survival in men with metastatic castration-resistant prostate cancer (mCRPC) receiving docetaxel and prednisone (DP). Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Fleming, MT
  • Pond, Gregory
  • Armstrong, AJ
  • Wood, BA
  • Brookes, M
  • Leopold, LH
  • Matveev, VB
  • Burke, JM
  • Caton, JR
  • Sonpavde, G

publication date

  • May 20, 2011